Hemorrhagic Shock - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Hemorrhagic Shock - Pipeline Review, H2 2016

Hemorrhagic Shock - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Hemorrhagic Shock - Pipeline Review, H2 2016
Published Aug 24, 2016
38 pages — Published Aug 24, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Hemorrhagic Shock - Pipeline Review, H2 2016, provides an overview of the Hemorrhagic Shock pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemorrhagic Shock, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hemorrhagic Shock and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Hemorrhagic Shock
- The report reviews pipeline therapeutics for Hemorrhagic Shock by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Hemorrhagic Shock therapeutics and enlists all their major and minor projects
- The report assesses Hemorrhagic Shock therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Hemorrhagic Shock


Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Hemorrhagic Shock
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Hemorrhagic Shock pipeline depth and focus of In

  
Source:
Document ID
GMDHC8380IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Hemorrhagic Shock Overview61
Therapeutics Development72
  Pipeline Products for Hemorrhagic Shock Overview71
  Pipeline Products for Hemorrhagic Shock Comparative Analysis81
Hemorrhagic Shock Therapeutics under Development by Companies91
Hemorrhagic Shock Therapeutics under Investigation by Universities/Institutes101
Hemorrhagic Shock Pipeline Products Glance112
  Clinical Stage Products111
  Early Stage Products121
Hemorrhagic Shock Products under Development by Companies131
Hemorrhagic Shock Products under Investigation by Universities/Institutes141
Hemorrhagic Shock Companies Involved in Therapeutics Development153
  Biomedica Management Corporation151
  Leading BioSciences, Inc.161
  NuvOx Pharma LLC171
Hemorrhagic Shock Therapeutics Assessment189
  Assessment by Monotherapy Products181
  Assessment by Target192
  Assessment by Mechanism of Action212
  Assessment by Route of Administration232
  Assessment by Molecule Type252
Drug Profiles278
  AM/AMBP-1 Drug Profile271
  LB-1148 Drug Profile282
  Neutrolide Drug Profile301
  NVX-408 Drug Profile311
  Recombinant Protein for Acute Kidney Injury, Acute Radiation Syndrome, Inflammatory Bowel Disease, Ischemic Organ Injury, and Sepsis Drug Profile321
  Synthetic Peptide to Inhibit TREM-1 for Oncology, Sepsis, Rheumatoid Arthritis and Hemorrhagic Shock Drug Profile331
  YW-356 Drug Profile341
Hemorrhagic Shock Dormant Projects351
Hemorrhagic Shock Discontinued Products361
Appendix372
  Methodology371
  Coverage371
  Secondary Research371
  Primary Research371
  Expert Panel Validation371
  Contact Us371
  Disclaimer381

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Hemorrhagic Shock - Pipeline Review, H2 2016" Aug 24, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Hemorrhagic-Shock-Pipeline-Review-H2-2016-2088-16422>
  
APA:
Global Markets Direct - Market Research. (2016). Hemorrhagic Shock - Pipeline Review, H2 2016 Aug 24, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Hemorrhagic-Shock-Pipeline-Review-H2-2016-2088-16422>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.